Microbix Biosystems Attains Health Canada Establishment Licensing

Ontario Industry Updates
Written By Guest User
Logo-2_large.png

Microbix Biosystems has attained medical devices establishment licensing from Health Canada, allowing the immediate use of its quality assessment products (QAPs™) by clinical laboratories across the country, including its QAPs to help ensure the accuracy of COVID-19 disease testing.

Guest User
Previous

Perimeter Medical Imaging Receives $10.4 Million Grant
Next

Spartan Bioscience Receives Health Canada Approval for Fast, Portable COVID-19 Test